BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Palmowski A, Buttgereit F. Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis. Curr Rheumatol Rep 2020;22:85. [PMID: 33047263 DOI: 10.1007/s11926-020-00961-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Christ L, Seitz L, Scholz G, Sarbu A, Amsler J, Bütikofer L, Tappeiner C, Kollert F, Reichenbach S, Villiger PM. Tocilizumab monotherapy after ultra-short glucocorticoid administration in giant cell arteritis: a single-arm, open-label, proof-of-concept study. The Lancet Rheumatology 2021;3:e619-26. [DOI: 10.1016/s2665-9913(21)00152-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
2 Watanabe R, Hashimoto M. Perspectives of JAK Inhibitors for Large Vessel Vasculitis. Front Immunol 2022;13:881705. [PMID: 35432355 DOI: 10.3389/fimmu.2022.881705] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Misra DP, Rathore U, Patro P, Agarwal V, Sharma A. Corticosteroid monotherapy for the management of Takayasu arteritis-a systematic review and meta-analysis. Rheumatol Int 2021;41:1729-42. [PMID: 34302232 DOI: 10.1007/s00296-021-04958-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]